Sugentech Inc. (KOSDAQ:253840)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,915.00
+195.00 (5.24%)
Jun 29, 2026, 3:30 PM KST
Market Cap59.86B -52.7%
Revenue (ttm)9.87B -1.5%
Net Income-24.47B
EPS-1,601.05
Shares Out 15.29M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume132,350
Open3,720.00
Previous Close3,720.00
Day's Range3,665.00 - 3,940.00
52-Week Range3,625.00 - 8,670.00
Beta0.53
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was ... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 144
Stock Exchange KOSDAQ
Ticker Symbol 253840
Full Company Profile

Financial Performance

In 2025, Sugentech's revenue was 9.42 billion, a decrease of -6.74% compared to the previous year's 10.10 billion. Losses were -23.31 billion, 53.5% more than in 2024.

Financial Statements